Company profile for Otsuka Holdings

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

In keeping with the corporate philosophy and Otsuka's mottos "JISSHO" (Proof through Execution) and "SOZOSEI" (Creativity), we strive to utilize our Group's unique assets and skills to develop differentiating scientific solutions which contribute to the lives of people worldwide in the form of innovative and creative products ranging from pharmaceuticals to consumer products. Otsuka Group is striving to cultivate a culture an...
In keeping with the corporate philosophy and Otsuka's mottos "JISSHO" (Proof through Execution) and "SOZOSEI" (Creativity), we strive to utilize our Group's unique assets and skills to develop differentiating scientific solutions which contribute to the lives of people worldwide in the form of innovative and creative products ranging from pharmaceuticals to consumer products. Otsuka Group is striving to cultivate a culture and a dynamic corporate climate reflecting our vision as a healthcare company.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Japan
Address
Address
2-9 Kanda-Tsukasamachi, Chiyoda-ku, Tokyo 101-0048
Telephone
Telephone
+81 (0)3-6717-1410
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761434

FDA
25 Nov 2025

https://www.businesswire.com/news/home/20251124043308/en/Otsuka-Pharmaceutical-Submits-New-Drug-Application-to-U.S.-FDA-for-Centanafadine-for-the-Treatment-of-ADHD-in-Children-Adolescents-and-Adults

BUSINESSWIRE
24 Nov 2025

https://www.fiercepharma.com/marketing/lundbeck-otsuka-back-survey-uncovering-blind-spot-around-alzheimers-agitation

FIERCE PHARMA
12 Nov 2025

https://www.globenewswire.com/news-release/2025/10/31/3178071/0/en/4DMT-Announces-Exclusive-License-Agreement-with-Otsuka-Pharmaceutical-Co-Ltd-for-Development-and-Commercialization-of-4D-150-in-Asia-Pacific.html

GLOBENEWSWIRE
30 Oct 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cantargia-closes-the-acquisition-of-can10-by-otsuka-1071672

ACCESSWIRE
11 Sep 2025

https://www.pharmiweb.com/press-release/2025-08-25/otsuka-medical-devices-receives-manufacturing-and-marketing-approval-for-paradise-ultrasound-renal-d

PHARMAWEB
25 Aug 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Otsuka Holdings and get a quotation

Otsuka Holdings is a supplier offers 3 products (APIs, Excipients or Intermediates).

Find a price of Difamilast bulk with DMF offered by Otsuka Holdings

Find a price of Oranekishijin hydrochloride hydrate bulk with JDMF offered by Otsuka Holdings

Find a price of Aripiprazole bulk offered by Otsuka Holdings

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty